PROPERTIES OF 4 ACUTE PHASE PROTEINS - C-REACTIVE PROTEIN, SERUM AMYLOID-A PROTEIN, ALPHA-1-ACID GLYCOPROTEIN, AND FIBRINOGEN

被引:244
作者
SCHULTZ, DR
机构
[1] Department of Medicine, University of Miami School of Medicine
[2] Department of Medicine, University of Miami School of Medicine
关键词
Acute phase proteins; C-reactive protein; fibrogen; serum amyloid A protein; α[!sub]1[!/sub]-acid glycoprotein;
D O I
10.1016/0049-0172(90)90055-K
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Four plasma proteins, referred to as positive acute phase proteins because of increases in concentration following inflammatory stimuli, are reviewed: C-reactive protein (CRP), serum amyloid A protein (SAA), α1-acid glycoprotein (AAG), and fibrinogen. The CRP and SAA may increase in concentration as much as 1000-fold, the AAG and fibrinogen approximately twofold to fourfold. All are synthesized mainly in the liver, but each may be produced in a number of extrahepatic sites. The role of cytokines in induction of the acute phase proteins is discussed, particularly the multiple functional capabilities of interleukin-6 (IL-6). Other cytokines that regulate acute phase gene expression and protein synthesis include IL-1, tumor necrosis factor α, interferon γ, as well as other stimulatory factors and cofactors. The physicochemical characteristics of each protein are reviewed together with the molecular biology. For each protein, the known biological effects are detailed. The following functions for CRP have been described: reaction with cell surface receptors resulting in opsonization, enhanced phagocytosis, and passive protection; activation of the classical complement pathway; scavenger for chromatin fragments; inhibition of growth and/or metastases of tumor cells; modulation of polymorphonuclear function; and a few additional diverse activities. The role of plasma SAA is described as a precursor of protein AA in secondary amyloidosis; other functions are speculative. AAG may play an immunoregulatory role as well as a role in binding a number of diverse drugs. In addition to clot formation, new data are described for binding of fibrinogen and fibrin to complement receptor type 3. Finally, the concentration of each protein is discussed in a wide variety of noninfectious and infectious disease states, particularly in connective tissue diseases. The quantification of the proteins during the course of various acute and chronic inflammatory disorders is useful in diagnosis, therapy, and in some cases, prognosis. © 1990.
引用
收藏
页码:129 / 147
页数:19
相关论文
共 172 条
[81]   THE PHENOMENON OF THE ACUTE PHASE RESPONSE [J].
KUSHNER, I .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1982, 389 (JUN) :39-48
[82]  
KUSHNER I, 1981, TXB RHEUMATOLOGY, P669
[83]   C-REACTIVE PROTEIN IS PRODUCED BY A SMALL NUMBER OF NORMAL HUMAN PERIPHERAL-BLOOD LYMPHOCYTES [J].
KUTA, AE ;
BAUM, LL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 164 (01) :321-326
[84]   MODULATION OF HUMAN POLYMORPHONUCLEAR NEUTROPHIL FUNCTIONS BY ALPHA-1-ACID GLYCOPROTEIN [J].
LAINE, E ;
COUDERC, R ;
ROCHARVEILLER, M ;
VASSON, MP ;
GIROUD, JP ;
RAICHVARG, D .
INFLAMMATION, 1990, 14 (01) :1-9
[85]  
LEI KJ, 1985, J BIOL CHEM, V260, P3377
[86]   IMMUNOLOGICAL STUDIES OF MAJOR NONIMMUNOGLOBULIN PROTEIN OF AMYLOID .1. IDENTIFICATION AND PARTIAL CHARACTERIZATION OF A RELATED SERUM COMPONENT [J].
LEVIN, M ;
PRAS, M ;
FRANKLIN, EC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1973, 138 (02) :373-380
[87]  
LOONEY RJ, 1986, J IMMUNOL, V136, P1641
[88]   MICROHETEROGENEITY FORMS OF ALPHA1-ACID GLYCOPROTEIN AS INDICATORS OF RHEUMATOID-ARTHRITIS ACTIVITY [J].
MACKIEWICZ, A ;
PAWLOWSKI, T ;
MACKIEWICZPAWLOWSKA, A ;
WIKTOROWICZ, K ;
MACKIEWICZ, S .
CLINICA CHIMICA ACTA, 1987, 163 (02) :185-190
[89]   SERUM IGA, ACUTE PHASE PROTEINS, AND GLYCOSYLATION OF ALPHA-1-ACID GLYCOPROTEIN IN ANKYLOSING-SPONDYLITIS [J].
MACKIEWICZ, A ;
KHAN, MA ;
REYNOLDS, TL ;
VANDERLINDEN, S ;
KUSHNER, I .
ANNALS OF THE RHEUMATIC DISEASES, 1989, 48 (02) :99-103
[90]   MONOKINES REGULATE GLYCOSYLATION OF ACUTE-PHASE PROTEINS [J].
MACKIEWICZ, A ;
GANAPATHI, MK ;
SCHULTZ, D ;
KUSHNER, I .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (01) :253-258